In numerous solid tumors such as ovarian cancer, melanoma, colorectal cancer, and hematological malignancies, including Hodgkin and diffuse large B-cell lymphoma, TILs with elevated LAG-3 expression have been identified [32]. Here, LAG3 is linked to melanoma.